Skip to main content

Latest stock market podcasts

Part 2 Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Weekly Wrap 4 February

Sophia Mavridis
February 4, 2022

Morning Bell 3 February

Paulina Peters
February 3, 2022

Morning Bell 2 February

Sophia Mavridis
February 2, 2022

Morning Bell 1 February

Paulina Peters
February 1, 2022

Morning Bell 31 January

Sophia Mavridis
January 31, 2022

Weekly Wrap 28 January

Sophia Mavridis
January 28, 2022

Morning Bell 27 January

Sophia Mavridis
January 27, 2022

Morning Bell 25 January

Paulina Peters
January 25, 2022

Morning Bell 24 January

Paulina Peters
January 24, 2022

Weekly Wrap 21 January

Sophia Mavridis
January 21, 2022

Morning Bell 20 January

Sophia Mavridis
January 20, 2022

Morning Bell 19 January

Sophia Mavridis
January 19, 2022